Formulation development of a continuously manufactured orodispersible film containing warfarin sodium for individualized dosing.


Journal

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
ISSN: 1873-3441
Titre abrégé: Eur J Pharm Biopharm
Pays: Netherlands
ID NLM: 9109778

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 09 08 2018
revised: 14 12 2018
accepted: 13 01 2019
pubmed: 21 1 2019
medline: 31 5 2019
entrez: 21 1 2019
Statut: ppublish

Résumé

Continuously manufactured orodispersible films (ODFs) offer a promising approach for individualized therapy with an easy to administer solid dosage form. The aim of this study was to develop a long ODF containing warfarin sodium to enable safe and more flexible dosing. Formulation development was conducted systematically for the continuous film coating process. A continuously working pilot-scale coating bench was used for film manufacturing and the viscosities of the polymer solutions were investigated to obtain processible formulations. The investigation of the mechanical properties of the long film was an integral part of the study, because the handling of the long film during flexible dosing differs distinctly from the handling of a single dosed ODF. The secant modulus and the yield stress were evaluated as parameters with high information value about the deformation behavior of the ODF. A long warfarin ODF was successfully produced using the pilot-scale coating bench equipped with an optical probe for in-line film thickness measurement. It was feasible to use the principle of a tape dispenser for flexible and, therefore, individualized dosing as proof of concept. Combining the long ODF with a dosing device allows individualized therapy with warfarin for all age groups manageable by the patient himself.

Identifiants

pubmed: 30660692
pii: S0939-6411(18)30998-6
doi: 10.1016/j.ejpb.2019.01.011
pii:
doi:

Substances chimiques

Anticoagulants 0
Drug Carriers 0
Warfarin 5Q7ZVV76EI

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

93-101

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Svenja Niese (S)

Heinrich Heine University Düsseldorf, Institute of Pharmaceutics and Biopharmaceutics, Universitätsstr. 1, 40225 Düsseldorf, Germany. Electronic address: svenja.niese@hhu.de.

Julian Quodbach (J)

Heinrich Heine University Düsseldorf, Institute of Pharmaceutics and Biopharmaceutics, Universitätsstr. 1, 40225 Düsseldorf, Germany. Electronic address: julian.quodbach@hhu.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation

UK Foot and Ankle Thromboembolism (UK-FATE).

Jitendra Mangwani, Linzy Houchen-Wolloff, Karan Malhotra et al.
1.00
Humans Venous Thromboembolism Male Female United Kingdom

Folate-engineered chitosan nanoparticles: next-generation anticancer nanocarriers.

Prashant Kesharwani, Kratika Halwai, Saurav Kumar Jha et al.
1.00
Chitosan Humans Folic Acid Nanoparticles Drug Carriers

Classifications MeSH